{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:17:05Z","timestamp":1789384625566,"version":"build-2803163510"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12,4]]},"DOI":"10.1093\/jnci\/djt318","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T03:19:21Z","timestamp":1384485561000},"page":"1814-1820","source":"Crossref","is-referenced-by-count":89,"title":["Racial Disparity in Consultation, Treatment, and the Impact on Survival in Metastatic Colorectal Cancer"],"prefix":"10.1093","volume":"105","author":[{"given":"Daniel R.","family":"Simpson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Elena","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jona","family":"Hattangadi-Gluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loren K.","family":"Mell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Heestand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Fanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Ramamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quynh-Thu","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,11,14]]},"reference":[{"issue":"1","key":"key\n\t\t\t\t20170518092944_CIT0001","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"key\n\t\t\t\t20170518092944_CIT0002","author":"National Comprehensive Cancer Network","year":"2013","journal-title":"Colon Cancer, Version 3.2013"},{"key":"key\n\t\t\t\t20170518092944_CIT0003","author":"National Comprehensive Cancer Network","year":"2013","journal-title":"Rectal Cancer, Version 4.2013"},{"issue":"4","key":"key\n\t\t\t\t20170518092944_CIT0004","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0895-4356(00)00316-4","article-title":"Racial differences in colorectal cancer mortality. The importance of stage and socioeconomic status","volume":"54","author":"Marcella","year":"2001","journal-title":"J Clin Epidemiol"},{"issue":"22","key":"key\n\t\t\t\t20170518092944_CIT0005","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/jnci\/87.22.1686","article-title":"Determinants of black\/white differences in colon cancer survival","volume":"87","author":"Mayberry","year":"1995","journal-title":"J Natl Cancer Inst"},{"issue":"17","key":"key\n\t\t\t\t20170518092944_CIT0006","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archinte.162.17.1985","article-title":"Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study","volume":"162","author":"Clegg","year":"2002","journal-title":"Arch Intern Med"},{"issue":"7","key":"key\n\t\t\t\t20170518092944_CIT0007","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1200\/JCO.2003.06.178","article-title":"Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort","volume":"21","author":"Ayanian","year":"2003","journal-title":"J Clin Oncol"},{"issue":"16","key":"key\n\t\t\t\t20170518092944_CIT0008","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/jnci\/dji241","article-title":"Explaining black-white differences in receipt of recommended colon cancer treatment","volume":"97","author":"Baldwin","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"key\n\t\t\t\t20170518092944_CIT0009","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.annepidem.2003.08.002","article-title":"Racial differences in the treatment of colorectal cancer: a comparison of surgical and radiation therapy between whites and blacks","volume":"14","author":"Demissie","year":"2004","journal-title":"Ann Epidemiol"},{"key":"key\n\t\t\t\t20170518092944_CIT0010","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.28143","article-title":"Changing prognosis of metastatic colorectal adenocarcinoma: differential improvement by age and tumor location","author":"Golan","year":"2013;119(16):3084\u20133091","journal-title":"Cancer"},{"issue":"10","key":"key\n\t\t\t\t20170518092944_CIT0011","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/jnci\/djn145","article-title":"Residual treatment disparities after oncology referral for rectal cancer","volume":"100","author":"Morris","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"key\n\t\t\t\t20170518092944_CIT0012","first-page":"515","article-title":"Racial\/ethnic and age disparities in chemotherapy selection for colorectal cancer","volume":"16","author":"Obeidat","year":"2010","journal-title":"Am J Manag Care"},{"issue":"4","key":"key\n\t\t\t\t20170518092944_CIT0013","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/cncr.26394","article-title":"Exploring racial differences in outcome and treatment for metastatic colorectal cancer: results from a large prospective observational cohort study (BRiTE)","volume":"118","author":"Polite","year":"2012","journal-title":"Cancer"},{"issue":"5","key":"key\n\t\t\t\t20170518092944_CIT0014","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1200\/JCO.2002.20.5.1192","article-title":"Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer","volume":"20","author":"Potosky","year":"2002","journal-title":"J Clin Oncol"},{"issue":"4","key":"key\n\t\t\t\t20170518092944_CIT0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1200\/JCO.2011.37.5527","article-title":"Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008","volume":"30","author":"Robbins","year":"2012","journal-title":"J Clin Oncol"},{"issue":"25","key":"key\n\t\t\t\t20170518092944_CIT0016","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1200\/JCO.2009.21.9527","article-title":"Racial differences in advanced colorectal cancer outcomes and pharmacogenetics: a subgroup analysis of a large randomized clinical trial","volume":"27","author":"Sanoff","year":"2009","journal-title":"J Clin Oncol"},{"issue":"19","key":"key\n\t\t\t\t20170518092944_CIT0017","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.2002.11.084","article-title":"Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer","volume":"20","author":"Schrag","year":"2002","journal-title":"J Clin Oncol"},{"issue":"19","key":"key\n\t\t\t\t20170518092944_CIT0018","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1002\/cncr.25395","article-title":"Racial disparities in colorectal cancer survival: to what extent are racial disparities explained by differences in treatment, tumor characteristics, or hospital characteristics?","volume":"116","author":"White","year":"2010","journal-title":"Cancer"},{"issue":"20","key":"key\n\t\t\t\t20170518092944_CIT0019","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/jnci\/djr310","article-title":"Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials","volume":"103","author":"Yothers","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"key\n\t\t\t\t20170518092944_CIT0020","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2105\/AJPH.82.5.703","article-title":"Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology","volume":"82","author":"Krieger","year":"1992","journal-title":"Am J Public Health"},{"issue":"12","key":"key\n\t\t\t\t20170518092944_CIT0021","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","article-title":"Development of a comorbidity index using physician claims data","volume":"53","author":"Klabunde","year":"2000","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"key\n\t\t\t\t20170518092944_CIT0022","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"key\n\t\t\t\t20170518092944_CIT0023","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"key\n\t\t\t\t20170518092944_CIT0024","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00005650-200208001-00007","article-title":"Studying radiation therapy using SEER-Medicare-linked data","volume":"40","author":"Virnig","year":"2002","journal-title":"Med Care"},{"key":"key\n\t\t\t\t20170518092944_CIT0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00005650-200208001-00008","article-title":"Utility of the SEER-Medicare data to identify chemotherapy use","volume":"40","author":"Warren","year":"2002","journal-title":"Med Care"},{"issue":"3","key":"key\n\t\t\t\t20170518092944_CIT0026","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1200\/JCO.2005.05.169","article-title":"Racial differences in surgical evaluation, treatment, and outcome of locoregional esophageal cancer: a population-based analysis of elderly patients","volume":"23","author":"Steyerberg","year":"2005","journal-title":"J Clin Oncol"},{"issue":"11","key":"key\n\t\t\t\t20170518092944_CIT0027","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1245\/s10434-009-0656-5","article-title":"Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma","volume":"16","author":"Murphy","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"key\n\t\t\t\t20170518092944_CIT0028","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.2002.07.142","article-title":"Impact of referral patterns on the use of chemotherapy for lung cancer","volume":"20","author":"Earle","year":"2002","journal-title":"J Clin Oncol"},{"issue":"16","key":"key\n\t\t\t\t20170518092944_CIT0029","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","article-title":"Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer","volume":"18","author":"de Gramont","year":"2000","journal-title":"J Clin Oncol"},{"issue":"13","key":"key\n\t\t\t\t20170518092944_CIT0030","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1200\/JCO.2006.09.0928","article-title":"Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest","volume":"25","author":"Falcone","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"key\n\t\t\t\t20170518092944_CIT0031","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1200\/JCO.2004.09.046","article-title":"A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer","volume":"22","author":"Goldberg","year":"2004","journal-title":"J Clin Oncol"},{"issue":"13","key":"key\n\t\t\t\t20170518092944_CIT0032","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200009283431302","article-title":"Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group","volume":"343","author":"Saltz","year":"2000","journal-title":"N Engl J Med"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/105\/23\/1814\/11771190\/djt318.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T18:07:31Z","timestamp":1503511651000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/djt318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,14]]},"references-count":32,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2013,11,14]]},"published-print":{"date-parts":[[2013,12,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djt318","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11,14]]}}}